Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
To be clear up front: Koi Peptides sells research-grade, sterile lyophilized GHK-Cu powder for in vitro laboratory study only
$20.00 Laboratory-grade water material supplied for analytical research applications involving peptide preparation, laboratory handling procedures, and controlled research workflows
Both remain in phase 3 clinical development programs [16]: Cagrilintide Status: Phase 3 trials ongoing for CagriSema (cagrilintide + semaglutide combination) Expected approval timeline: 2027-2028 for the combination product Monotherapy development pathway unclear Retatrutide Status: Phase 3 trials initiated in 2024-2025 Monotherapy development for obesity and metabolic dysfunction Expected approval timeline: 2028-2029 if trials succeed This regulatory status means any use of these compounds, whether individually or in cagrilintide dosage with retatrutide combinations, occurs in research contexts or through off-label prescribing once (if) individual approvals are obtained
Unlike many peptides used in research, BPC-157 has been described in the published literature as stable in human gastric juice without enzymatic degradation, and as effective in research models when administered without a delivery carrier
Robinson, and M.J
